{{Rsnum
|rsid=16996151
|Gene=FAM13A
|Chromosome=4
|position=89057649
|Orientation=plus
|GMAF=0.01286
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=FAM13A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 2.1 | 17.8 | 80.1
| ASW | 0.0 | 8.9 | 91.1
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 6.5 | 93.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.6 | 99.4
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=0.000006
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs16996151
|overall_frequency_n=4
|overall_frequency_d=128
|overall_frequency=0.03125
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=4
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}